BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2417940)

  • 1. Class I genes and molecules: an update.
    Lew AM; Lillehoj EP; Cowan EP; Maloy WL; van Schravendijk MR; Coligan JE
    Immunology; 1986 Jan; 57(1):3-18. PubMed ID: 2417940
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular and functional characterization of a dominant minor H antigen, H60.
    Malarkannan S; Shih PP; Eden PA; Horng T; Zuberi AR; Christianson G; Roopenian D; Shastri N
    J Immunol; 1998 Oct; 161(7):3501-9. PubMed ID: 9759870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No functional gamma-chain transcripts detected in an alloreactive cytotoxic T-cell clone.
    Rupp F; Frech G; Hengartner H; Zinkernagel RM; Joho R
    Nature; 1986 Jun 26-Jul 2; 321(6073):876-8. PubMed ID: 3014341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR beta loci.
    Wu S; Saunders TL; Bach FH
    Nature; 1986 Dec 18-31; 324(6098):676-9. PubMed ID: 3099214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal expression in CD4 or CD8 subsets of different members of the V alpha 11 gene family correlates with sequence polymorphism.
    Sim BC; Gascoigne NR
    J Immunol; 1999 Mar; 162(6):3153-9. PubMed ID: 10092765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTL cross-reactivities reveal shared immunodominant determinants created by structurally homologous regions of MHC class I antigens.
    Hunt P; Sears DW
    J Immunol; 1983 Mar; 130(3):1439-46. PubMed ID: 6185588
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the major histocompatibility complex.
    Klein J; Figueroa F
    Crit Rev Immunol; 1986; 6(4):295-386. PubMed ID: 3536303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of murine major histocompatibility Class I antigen: assignment of putative allodeterminants to distinct positions of the amino acid sequence within the first external domain of the antigen.
    Ozato K; Takahashi H; Appella E; Sears DW; Murre C; Seidman JG; Kimura S; Tada N
    J Immunol; 1985 Mar; 134(3):1749-58. PubMed ID: 2578519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of class I genes in the mammalian major histocompatibility complex.
    Mellor AL
    Oxf Surv Eukaryot Genes; 1986; 3():95-140. PubMed ID: 3334367
    [No Abstract]   [Full Text] [Related]  

  • 13. An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus.
    Mayrand SM; Schwarz DA; Green WR
    J Immunol; 1998 Jan; 160(1):39-50. PubMed ID: 9551954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
    Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.
    Bazhan SI; Belavin PA; Seregin SV; Danilyuk NK; Babkina IN; Karpenko LI; Nekrasova NA; Lebedev LR; Ignatyev GM; Agafonov AP; Poryvaeva VA; Aborneva IV; Ilyichev AA
    Vaccine; 2004 Apr; 22(13-14):1672-82. PubMed ID: 15068850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.
    Hosono S; Tai PC; Wang W; Ambrose M; Hwang DG; Yuan TT; Peng BH; Yang CS; Lee CS; Shih C
    Virology; 1995 Sep; 212(1):151-62. PubMed ID: 7545853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.
    Petrányi GG
    Folia Biol (Praha); 1995; 41(3-4):163-77. PubMed ID: 7589712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-duplication of olfactory receptor and MHC class I genes in the mouse major histocompatibility complex.
    Amadou C; Younger RM; Sims S; Matthews LH; Rogers J; Kumanovics A; Ziegler A; Beck S; Lindahl KF
    Hum Mol Genet; 2003 Nov; 12(22):3025-40. PubMed ID: 14506126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is normal MHC class I and II expression constitutive or induced?
    Cockfield SM; Urmson J; Pleasants J; Halloran PF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):630-1. PubMed ID: 2468226
    [No Abstract]   [Full Text] [Related]  

  • 20. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
    Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
    J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.